Related Experiment Video

Updated: May 17, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.5K

Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy

Mohammed Alrouji1, Mohammed S Alshammari2, Saleha Anwar3

  • 1Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra 11961, Saudi Arabia.

Cancers
|May 14, 2025
PubMed

Insights

Cyclin-dependent kinases (CDKs) regulate cell cycle and transcription, crucial for cancer. Targeting these kinases, especially transcriptional CDKs, shows therapeutic promise but faces challenges in selectivity and off-target effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and transcription.
  • Dysregulated CDK activity is a hallmark of cancer, driving uncontrolled cell division and tumor growth.
  • CDKs are broadly classified into cell cycle-associated (e.g., CDK1, 2, 4, 6) and transcription-associated (e.g., CDK7, 8, 9, 12, 13) types.

Purpose of the Study:

  • To review the non-transcriptional roles of CDKs in cancer biology.
  • To explore the therapeutic potential of targeting CDKs in various malignancies.
  • To highlight the challenges associated with developing selective CDK inhibitors for cancer treatment.

Main Methods:

  • Literature review of existing research on CDK functions in cancer.
  • Analysis of therapeutic strategies targeting CDKs, including approved drugs and ongoing research.
  • Discussion of the complexities in achieving kinase selectivity and minimizing off-target effects.

Main Results:

  • Targeting transcriptional CDKs offers a promising therapeutic avenue by modulating RNA polymerase II activity and gene expression.
  • CDK4/6 inhibitors (palbociclib, ribociclib) have shown efficacy in breast cancer treatment.
  • CDK7, CDK8, and CDK9 are implicated in oncogenesis across multiple cancer types, making them attractive therapeutic targets.

Conclusions:

  • Despite advancements, developing selective CDK inhibitors with minimal off-target effects remains a significant challenge.
  • Further research is needed to optimize therapeutic strategies targeting CDKs for improved patient outcomes.
  • Understanding the diverse roles of CDKs in cancer is crucial for advancing targeted therapies.
Keywords:
CDK inhibitorscancer therapeuticscyclin-dependent kinases (CDKs)kinase-targeted therapytranscriptional CDKs

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.5K

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K